Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)

v3.8.0.1
Note 12 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues $ 6,545,851 $ 5,503,590 $ 18,234,516 $ 14,742,668
Operating income (loss) (377,630) (2,618,494) (2,949,169) (9,286,463)
Depreciation and amortization 468,800 695,579 1,550,013 1,908,238
Other (expense) income, net 9,907 5,877 (33,589) 5,200
Loss before income tax expense (367,723) (2,612,617) (2,982,758) (9,281,263)
Operating Segments [Member]        
Operating income (loss) 1,475,000 (332,000) 3,246,000 (1,666,000)
Corporate, Non-Segment [Member]        
Operating income (loss) (1,853,000) (2,287,000) (6,195,000) (7,620,000)
Corporate Clinics [Member]        
Revenues 2,930,000 2,341,000 8,106,000 6,137,000
Operating income (loss) (196,000) (1,527,000) (1,233,000) (4,863,000)
Depreciation and amortization 379,000 599,000 1,222,000 1,625,000
Franchise Operations [Member]        
Revenues 3,616,000 3,163,000 10,128,000 8,605,000
Operating income (loss) 1,671,000 1,195,000 4,479,000 3,197,000
Depreciation and amortization
Corporate Segment [Member]        
Depreciation and amortization $ 90,000 $ 97,000 $ 328,000 $ 283,000